Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.

about

Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections.

P2860

Q47644739-D61794A0-54AD-4B7C-B135-55976EBE2FA8

P2860

Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.

Item

http://www.wikidata.org/entity/Q41229114

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effect of teicoplanin on Staph ...... infective endocarditis model.

@en

type

Item

label

Effect of teicoplanin on Staph ...... infective endocarditis model.

@en

prefLabel

Effect of teicoplanin on Staph ...... infective endocarditis model.

@en

P1476

Effect of teicoplanin on Staph ...... infective endocarditis model.

@en

P2093

Attila Brassai

http://www.w3.org/2001/XMLSchema#string

Bogdan Cordoş

http://www.w3.org/2001/XMLSchema#string

Edit Székely

http://www.w3.org/2001/XMLSchema#string

Krisztina E Vas

http://www.w3.org/2001/XMLSchema#string

Szende Vancea

http://www.w3.org/2001/XMLSchema#string

Árpád Török

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.

Glycopeptide antibiotics: from conventional molecules to new derivatives.

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.

Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.

Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection

Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.

P304

446-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/1973947815Y.0000000031

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25976829

http://www.w3.org/2001/XMLSchema#string

Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.

about

P2860

P2860

Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698